These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ; Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151 [TBL] [Abstract][Full Text] [Related]
11. Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome? Lendrem D; Mitchell S; McMeekin P; Gompels L; Hackett K; Bowman S; Price E; Pease CT; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng WF; Rheumatology (Oxford); 2015 Apr; 54(4):655-9. PubMed ID: 25240612 [TBL] [Abstract][Full Text] [Related]
12. Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors. Quartuccio L; Gandolfo S; Zabotti A; Zandonella Callegher S; Fabro C; De Vita S Front Immunol; 2019; 10():1527. PubMed ID: 31354708 [No Abstract] [Full Text] [Related]
13. Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's. Cooper C; Wratten S; Williams-Hall R; Bookman AAM; Ndife B; Hueber W; Goswami P Rheumatol Ther; 2022 Dec; 9(6):1499-1515. PubMed ID: 36114443 [TBL] [Abstract][Full Text] [Related]
14. Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry. Dumusc A; Ng WF; James K; Griffiths B; Price E; Pease C; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Gupta M; McLaren J; Cooper A; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman S Swiss Med Wkly; 2018; 148():w14588. PubMed ID: 29442344 [TBL] [Abstract][Full Text] [Related]
15. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography. Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial. Bowman SJ; Fox R; Dörner T; Mariette X; Papas A; Grader-Beck T; Fisher BA; Barcelos F; De Vita S; Schulze-Koops H; Moots RJ; Junge G; Woznicki JN; Sopala MA; Luo WL; Hueber W Lancet; 2022 Jan; 399(10320):161-171. PubMed ID: 34861168 [TBL] [Abstract][Full Text] [Related]
17. Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies. Seror R; Meiners P; Baron G; Bootsma H; Bowman SJ; Vitali C; Gottenberg JE; Theander E; Tzioufas A; De Vita S; Ramos-Casals M; Dörner T; Quartuccio L; Ravaud P; Mariette X; Ann Rheum Dis; 2016 Nov; 75(11):1945-1950. PubMed ID: 27150113 [TBL] [Abstract][Full Text] [Related]
18. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Seror R; Ravaud P; Mariette X; Bootsma H; Theander E; Hansen A; Ramos-Casals M; Dörner T; Bombardieri S; Hachulla E; Brun JG; Kruize AA; Praprotnik S; Tomsic M; Gottenberg JE; Devauchelle V; Devita S; Vollenweider C; Mandl T; Tzioufas A; Carsons S; Saraux A; Sutcliffe N; Vitali C; Bowman SJ; Ann Rheum Dis; 2011 Jun; 70(6):968-72. PubMed ID: 21345815 [TBL] [Abstract][Full Text] [Related]
19. Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Ramos-Casals M; Brito-Zerón P; Seror R; Bootsma H; Bowman SJ; Dörner T; Gottenberg JE; Mariette X; Theander E; Bombardieri S; De Vita S; Mandl T; Ng WF; Kruize A; Tzioufas A; Vitali C; Rheumatology (Oxford); 2015 Dec; 54(12):2230-8. PubMed ID: 26231345 [TBL] [Abstract][Full Text] [Related]
20. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome. Brito-Zerón P; Acar-Denizli N; Ng WF; Horváth IF; Rasmussen A; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnstrom M; Praprotnik S; Sene D; Gerli R; Solans R; Rischmueller M; Mandl T; Suzuki Y; Isenberg D; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura H; Giacomelli R; Devauchelle-Pensec V; Hofauer B; Bombardieri M; Trevisani VFM; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenweider C; Zeher M; Sivils K; Xu B; Bombardieri S; Sandhya P; De Vita S; Minniti A; Sánchez-Guerrero J; Kilic L; van der Heijden E; Park SH; Wahren-Herlenius M; Mariette X; Ramos-Casals M; Rheumatology (Oxford); 2020 Sep; 59(9):2350-2359. PubMed ID: 31873754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]